Extravasation in Nuclear Medicine: Ron Lattanze of Lucerno Dynamics

ISAVE That Podcast

How does extravasation affect nuclear medicine? In what ways does vascular access impact nuclear medicine? The ISAVE That Podcast welcomes Ron Lattanze, the CEO of Lucerno Dynamics, to the show to answer these questions and more through data and further research ahead of the closing of a public comment period for a petition he spearheaded to the Nuclear Regulatory Commission.
0:00 AVA President Lori Kaczmarek, AVA Director of Clinical Education Judy Thompson and AVA Director of Communications Eric Seger kick off Episode 8
1:23 Lucerno Dynamics CEO Ron Lattanze Joins the Show
2:00 Extravasation in Nuclear Medicine
7:30 How Nuclear Medicine Impacts Vascular Access
10:00 How Do We Address This Issue?
13:31 A Deeper Explanation for Extravasation in Nuclear Medicine
16:55 Extravasation in Nuclear Medicine is Preventable
28:55 Public Comment at the Nuclear Regulatory Commission
35:12 Comments Due by November 30

Support the Show.

Chapters

1. Welcome to Episode 8 (00:00:00)

2. Lucerno Dynamics CEO Ron Lattanze Joins the Show (00:01:23)

3. Extravasation in Nuclear Medicine (00:02:00)

4. How Nuclear Medicine Impacts Vascular Access (00:07:30)

5. How Do We Address This Issue? (00:10:00)

6. A Deeper Explanation for Extravasation in Nuclear Medicine (00:13:31)

7. Extravasation in Nuclear Medicine is Preventable (00:16:55)

8. Public Comment at the Nuclear Regulatory Commission (00:28:55)

9. Comments Due by November 30 (00:35:12)